Balentine LLC Boston Scientific Corp Transaction History

Balentine LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$45.09 - $50.03 $27,865 - $30,918	618 Added 14.16%	4,981 $249,000
Q4 2022 Jan 31, 2023	BUY	$39.56 - $47.22 $172,600 - $206,020	4,363 New	4,363 $201,000
Q2 2022 Oct 26, 2022	SELL	$35.24 - $47.1 $141,770 - $189,483	-4,023 Reduced 33.42%	8,013 $299,000
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $282,378 - $377,412	8,013 New	8,013 $299,000
Q1 2022 Oct 26, 2022	BUY	$40.9 - $45.1 $164,540 - $181,437	4,023 Added 50.21%	12,036 $533,000
Q4 2021 Feb 02, 2022	SELL	$38.07 - $44.87 $176,416 - $207,927	-4,634 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $191,059 - $212,607	4,634 New	4,634 $201,000
Q3 2020 Nov 02, 2020	SELL	$34.44 - $42.23 $14,223 - $17,440	-413 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $4,558 - $5,905	151 Added 57.63%	413 $15,000
Q1 2020 May 18, 2020	SELL	$25.83 - $45.71 $44,892 - $79,443	-1,738 Reduced 86.9%	262 $9,000
Q4 2019 Sep 02, 2020	BUY	$37.87 - $45.37 $64,871 - $77,718	1,713 Added 596.86%	2,000 $90,000
Q3 2019 Nov 15, 2019	BUY	$40.31 - $43.45 $3,386 - $3,649	84 Added 41.38%	287 $12,000
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $7,086 - $8,724	203 New	203 $9,000
Q1 2018 May 16, 2018	SELL	$25.2 - $28.54 $15,346 - $17,380	-609 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $15,097 - $18,148	609	609 $15,000

1,566

1.18B

6.78M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $146B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.